Cell Care Therapeutics Overview
- Founded
-
2014

- Status
-
Private
- Employees
-
7

- Latest Deal Type
-
Later Stage VC
- Investors
-
1
Cell Care Therapeutics General Information
Description
Developer of regenerative immunotherapies designed to harness a patient's own immune system. The company's new class of biologics is derived from the secretions of adult stem/progenitor cells and is comprised of well-characterized therapeutic components including proteins, exosomes, and microRNAs, enabling patients to resolve inflammation and initiate tissue remodeling through the delivery of growth factors and enzymes to enhance innate regenerative pathways.
Contact Information
Website
www.cell-care.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
- 750 Royal Oaks Drive
- Suite 106
- Monrovia, CA 91016
- United States
+1 (562) 000-0000
Cell Care Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Later Stage VC | 01-May-2022 | 00.000 | Completed | Generating Revenue | ||
1. Seed Round | 23-Oct-2018 | 00.000 | 00.000 | Completed | Startup |
Cell Care Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of regenerative immunotherapies designed to harness a patient's own immune system. The company's new class of
Biotechnology
Monrovia, CA
7
As of 2022
00.000
0000000000 0
00.000
Cell Care Therapeutics Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Aruna Bio | Venture Capital-Backed | Athens, GA | 00 | 000.00 | 0000000000 | 000.00 |
0000000 0000000000 | Venture Capital-Backed | San Juan Capistrano, CA | 0 | 000.00 | 0000000000 0 | 000.00 |
0000000 0000000000 | Venture Capital-Backed | Pittsburgh, PA | 00 | 000.00 | 00000000000 | 000.00 |
Cell Care Therapeutics Patents
Cell Care Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2017218143-A1 | Adipose tissue derived mesenchymal stromal cell conditioned media and methods of making and using the same | Pending | 12-Feb-2016 | 0000000000 | |
CA-3010916-A1 | Adipose tissue derived mesenchymal stromal cell conditioned media and methods of making and using the same | Pending | 12-Feb-2016 | 000000000 | |
EP-3414320-A1 | Adipose tissue derived mesenchymal stromal cell conditioned media and methods of making and using the same | Pending | 12-Feb-2016 | 0000000000 | |
US-20190046576-A1 | Adipose tissue derived mesenchymal stromal cell conditioned media and methods of making and using the same | Pending | 12-Feb-2016 | A61K35/28 |
Cell Care Therapeutics Executive Team (4)
Cell Care Therapeutics Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
Daniel Gil Ph.D | Self | Board Member | 000 0000 |
Mario Molina MD | Self | Board Member | 000 0000 |
Nicolas Sohl | Cell Care Therapeutics | Co-Founder, Chief Executive Officer, President and Chairman | 000 0000 |
Cell Care Therapeutics Signals
Cell Care Therapeutics Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
StartX (US) | Venture Capital | Minority | 000 0000 | 000000 0 |